Crestline Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2,789	Closed	-$1.99M	–	507
2024 Q4	$1.99M	Buy	2,789 +2,013	+259%	+$1.43M	0.07%	281
2024 Q3	$816K	Buy	+776	New	+$816K	0.04%	289
2019 Q4	–	Sell	-28,500	Closed	-$7.91M	–	84
2019 Q3	$7.91M	Buy	+28,500	New	+$7.91M	1.27%	13